Published in PLoS One on June 14, 2013
Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging (2013) 1.00
Brain sex matters: estrogen in cognition and Alzheimer's disease. Mol Cell Endocrinol (2014) 0.88
The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study. BMC Med (2015) 0.84
Greater cognitive decline with aging among elders with high serum concentrations of organochlorine pesticides. PLoS One (2015) 0.78
Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study. J Neuroinflammation (2014) 0.78
Post-stroke memory impairment among patients with vascular mild cognitive impairment. BMC Neurol (2014) 0.77
Visual Impairment, Hearing Loss and Cognitive Function in an Older Population: Longitudinal Findings from the Blue Mountains Eye Study. PLoS One (2016) 0.77
The Rate of Age-Related Olfactory Decline Among the General Population of Older U.S. Adults. J Gerontol A Biol Sci Med Sci (2015) 0.77
Postmortem MRI: a novel window into the neurobiology of late life cognitive decline. Neurobiol Aging (2016) 0.76
Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies. Neurology (2016) 0.75
Coronary heart disease and risk for cognitive impairment or dementia: Systematic review and meta-analysis. PLoS One (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc (2002) 9.81
The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimers Dement (2006) 5.05
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med (2009) 4.45
Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med (2010) 3.67
Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10
Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis. J Neurol Neurosurg Psychiatry (2008) 2.90
Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope (1996) 2.78
Kidney function is associated with the rate of cognitive decline in the elderly. Neurology (2009) 2.27
Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry (2008) 2.26
Activity energy expenditure and incident cognitive impairment in older adults. Arch Intern Med (2011) 2.07
Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med (2010) 2.04
Early olfactory involvement in Alzheimer's disease. Can J Neurol Sci (2003) 1.74
Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology (1999) 1.72
Education and Cognitive Decline in Older Americans: Results From the AHEAD Sample. Res Aging (2007) 1.57
Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry (2008) 1.56
The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord (1998) 1.53
The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int Psychogeriatr (2010) 1.32
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology (2012) 1.31
Preclinical syndromes predict dementia: the Sydney older persons study. J Neurol Neurosurg Psychiatry (2001) 1.30
Association between apolipoprotein E4 and cognitive decline in elderly adults. J Am Geriatr Soc (2007) 1.29
Odor identification and decline in different cognitive domains in old age. Neuroepidemiology (2005) 1.28
Effects of sociodemographic and health variables on Mini-Mental State Exam scores in older Australians. Am J Geriatr Psychiatry (2007) 1.15
Progression of cognitive impairment in stroke patients. Neurology (2004) 1.14
The positive impact of physical activity on cognition during adulthood: a review of underlying mechanisms, evidence and recommendations. Rev Neurosci (2011) 1.11
APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology (2004) 1.10
Estimating the incidence of dementia: the impact of adjusting for subject attrition using health care utilization data. Ann Epidemiol (2005) 1.04
Late life leisure activities and risk of cognitive decline. J Gerontol A Biol Sci Med Sci (2012) 1.04
Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology (2002) 1.02
Impact of cardiovascular risk factors on cognitive function: the Tromsø study. Eur J Neurol (2010) 1.00
Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors. Cancer Epidemiol (2010) 0.99
Risk profiles of subtypes of mild cognitive impairment: the sydney memory and ageing study. J Am Geriatr Soc (2011) 0.99
Body mass index across midlife and cognitive change in late life. Int J Obes (Lond) (2012) 0.96
Risk profiles for mild cognitive impairment vary by age and sex: the Sydney Memory and Ageing study. Am J Geriatr Psychiatry (2012) 0.94
Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors. J Neurol (2009) 0.93
Cognitive impairment as predictor of functional dependence in an elderly sample. Arch Gerontol Geriatr (2011) 0.91
Severe dysosmia is specifically associated with Alzheimer-like memory deficits in nondemented elderly retirees. Neuroepidemiology (2002) 0.90
Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics. J Alzheimers Dis (2011) 0.90
Cognitive deficits in the remitted state of unipolar depressive disorder. Neuropsychology (2012) 0.88
Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients. Diabetes Res Clin Pract (2012) 0.87
The effect of education on the onset and rate of terminal decline. Psychol Aging (2011) 0.86
Cognitive impairment and diabetes. Recent Pat Endocr Metab Immune Drug Discov (2013) 0.81
Global prevalence of dementia: a Delphi consensus study. Lancet (2005) 23.30
Mild cognitive impairment. Lancet (2006) 10.21
Treatment of acute achilles tendon ruptures. A meta-analysis of randomized, controlled trials. J Bone Joint Surg Am (2005) 3.17
Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy. Dement Geriatr Cogn Disord (2010) 2.49
Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial. Lancet Neurol (2009) 2.38
Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics (2013) 2.11
Determinants of disparities between perceived and physiological risk of falling among elderly people: cohort study. BMJ (2010) 2.02
Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care (2013) 1.99
A multifactorial approach to understanding fall risk in older people. J Am Geriatr Soc (2010) 1.97
Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Curr Opin Neurol (2008) 1.92
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol (2009) 1.86
A three-country randomized controlled trial of a psychosocial intervention for caregivers combined with pharmacological treatment for patients with Alzheimer disease: effects on caregiver depression. Am J Geriatr Psychiatry (2008) 1.81
An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry (2011) 1.80
Multiple biological pathways link cognitive lifestyle to protection from dementia. Biol Psychiatry (2011) 1.79
Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging. Radiology (2007) 1.77
Prevalence, incidence, and risk factors of lacunar infarcts in a community sample. Neurology (2009) 1.64
Discrete neuroanatomical networks are associated with specific cognitive abilities in old age. J Neurosci (2011) 1.61
Lifespan mental activity predicts diminished rate of hippocampal atrophy. PLoS One (2008) 1.59
Abnormalities of the fornix in mild cognitive impairment are related to episodic memory loss. J Alzheimers Dis (2012) 1.52
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Nursing home staff attitudes towards residents with dementia: strain and satisfaction with work. J Adv Nurs (2003) 1.51
The Falls Efficacy Scale International (FES-I). A comprehensive longitudinal validation study. Age Ageing (2010) 1.48
A randomized trial to reduce the prevalence of depression and self-harm behavior in older primary care patients. Ann Fam Med (2012) 1.47
A systematic review of different models of home and community care services for older persons. BMC Health Serv Res (2011) 1.46
Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology (2007) 1.44
The effect of risperidone on nursing burden associated with caring for patients with dementia. J Am Geriatr Soc (2004) 1.44
The neglect of somatoform disorders by old age psychiatry: some explanations and suggestions for future research. Int J Geriatr Psychiatry (2003) 1.43
Magnetic resonance spectroscopy in cognitive research. Brain Res Brain Res Rev (2004) 1.42
Prevalence and predictors of “subjective cognitive complaints” in the Sydney Memory and Ageing Study. Am J Geriatr Psychiatry (2010) 1.41
Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment. J Neurol Neurosurg Psychiatry (2010) 1.41
Management of behavioral problems in Alzheimer's disease. Int Psychogeriatr (2010) 1.38
Mild cognitive impairment: evaluation with 4-T functional MR imaging. Radiology (2006) 1.37
APOE genotype and cognitive functioning in a large age-stratified population sample. Neuropsychology (2007) 1.33
The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int Psychogeriatr (2010) 1.32
Sex differences in regional gray matter in healthy individuals aged 44-48 years: a voxel-based morphometric study. Neuroimage (2007) 1.31
An emotional Stroop functional MRI study of euthymic bipolar disorder. Bipolar Disord (2005) 1.30
White matter integrity in mild cognitive impairment: a tract-based spatial statistics study. Neuroimage (2010) 1.30
Mild cognitive impairment. Lancet (2006) 1.27
IPA survey of brief cognitive screening instruments. Int Psychogeriatr (2006) 1.26
Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage (2005) 1.25
Meta-analysis of plasma amyloid-β levels in Alzheimer's disease. J Alzheimers Dis (2011) 1.25
Impact of white matter lesions on physical functioning and fall risk in older people: a systematic review. Stroke (2011) 1.25
The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Int J Geriatr Psychiatry (2007) 1.24
Cognitive and memory training in adults at risk of dementia: a systematic review. BMC Geriatr (2011) 1.24
Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI. Neurology (2012) 1.23
In vivo hippocampal measurement and memory: a comparison of manual tracing and automated segmentation in a large community-based sample. PLoS One (2009) 1.22
Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol (2010) 1.21
Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia. Int Psychogeriatr (2012) 1.20
McCune-Albright syndrome and disorders due to activating mutations of GNAS1. J Pediatr Endocrinol Metab (2007) 1.19
A systematic review of elderly suicide prevention programs. Crisis (2011) 1.18
Overweight and obesity affect treatment response in major depression. Biol Psychiatry (2007) 1.18
Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol Med (2005) 1.18
Should older adults be screened for dementia? Alzheimers Dement (2006) 1.17
Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs (2009) 1.17
Falls, depression and antidepressants in later life: a large primary care appraisal. PLoS One (2008) 1.16
Effects of sociodemographic and health variables on Mini-Mental State Exam scores in older Australians. Am J Geriatr Psychiatry (2007) 1.15